Hikma Pharmaceuticals PLCLSE: HIK

Hikma Pharmaceuticals: Holding(s) in Company

· Issued by Hikma Pharmaceuticals PLC via RNS

Summary by 6ix AI

Wellington Management Group LLP of Boston, United States, notified Hikma Pharmaceuticals PLC that on October 19, 2026 its holding crossed a level that requires it to notify the company. Its voting rights through shares rose to 5.03% from 4.97% in its previous notification, and its total rose to 5.08% from 5.02%. Hikma was notified on October 21, 2026.

Key details

  • Total voting rights held: 10,610,731. Of these, 10,494,821 (5.03%) are attached to shares and 115,910 (0.05%) are held through financial instruments, unchanged at 0.05% from the previous notification.
  • The financial instruments are two cash-settled equity swaps (contracts tied to the share price, paid in cash rather than shares): 92,594 voting rights (0.04%) expiring May 5, 2028, and 23,316 voting rights (0.01%) expiring May 20, 2033.
  • The holdings are held through two chains of Wellington entities, ending in the investment managers Wellington Management Europe GmbH and Wellington Management Company LLP, which manage assets of certain funds and/or managed accounts.

6ix AI wrote this summary from the release below and checked it against the release.

Hikma Pharmaceuticals Plc
21 October 2026
 

TR-1: Standard form for notification of major holdings

 LONDON, 21 October 2026 – Hikma Pharmaceuticals PLC (LEI:549300BNS685UXH4JI75)
(LSE: HIK) (NasdaqDubai: HIK) announces as follows:

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Hikma Pharmaceuticals Public Limited Company

1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an “X”)

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Wellington Management Group LLP

City and country of registered office (if applicable)

Boston, United States

4. Full name of shareholder(s) (if different from 3.)v

Name

VIDACOS NOMINEES LIMITED

State Street Nominees Limited

ROY Nominees Limited

Nortrust Nominees Limited

Mellon Nominees (UK) Ltd.

JP Morgan Chase Nominees Limited

HSBC Global Custody Nominee (UK) Limited

Euroclear Nominees Limited

BEST INVESTMENT CORP-WELLINGTON GHC

BBH ISL NOMINEES LTD

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

19/10/2026

6. Date on which issuer notified (DD/MM/YYYY):

21/10/2026

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuervii

Resulting situation on the date on which threshold was crossed or reached

5.030000

0.050000

5.080000

10610731

Position of previous notification (if

applicable)

4.970000

0.050000

5.020000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type of
shares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B0LCW083

10494821

5.030000

SUBTOTAL 8. A

10494821

5.030000%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expiration
datex

Exercise/
Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Sub Total 8.B1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration
datex

Exercise/
Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

Equity swap

05/05/2028

05/05/2028

Cash

92594

0.040000

Equity Swap

20/05/2033

20/05/2033

Cash

23316

0.010000

Sub Total 8.B2

115910

0.050000%

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an “X”)

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Wellington Management Group LLP (Chain 1)

Wellington Group Holdings LLP

5.030000

5.080000%

Wellington Management Group LLP (Chain 1)

Wellington Investment Advisors Holdings LLP

5.030000

5.080000%

Wellington Management Group LLP (Chain 1)

Wellington Management Global Holdings, Ltd.

Wellington Management Group LLP (Chain 1)

Wellington Management Europe GmbH

Wellington Management Group LLP (Chain 2)

Wellington Group Holdings LLP

5.030000

5.080000%

Wellington Management Group LLP (Chain 2)

Wellington Investment Advisors Holdings LLP

5.030000

5.080000%

Wellington Management Group LLP (Chain 2)

Wellington Management Company LLP

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Wellington Management Europe GmbH is an investment management entity that manages the assets of certain funds and/or managed accounts.


Wellington Management Europe GmbH is a direct controlled undertakings of Wellington Management Global Holdings, Ltd., which, in turn, is a direct controlled undertaking of Wellington Investment Advisors Holdings LLP, which, in turn, is a direct controlled undertaking of Wellington Group Holdings LLP, which, in turn, is a direct controlled undertaking of Wellington Management Group LLP.

Wellington Management Company LLP is an investment management entity that manages the assets of certain funds and/or managed accounts.


Wellington Management Company LLP is a direct controlled undertaking of Wellington Investment Advisors Holdings LLP, which, in turn, is a direct controlled undertaking of Wellington Group Holdings LLP, which, in turn, is a direct controlled undertaking of Wellington Management Group LLP.

Place of completion

London, UK

Date of completion

21-Oct-2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Hikma Pharmaceuticals PLC on 6ix

Earlier from Hikma Pharmaceuticals

All Hikma Pharmaceuticals news releases